Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma-Reference-Cited by-同舟云学术

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Published:2018-02 Issue:4 Volume:28 Page:769-773
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Czudor Zsófia,Balogh Mária,Bánhegyi Péter,Boros Sándor,Breza Nóra,Dobos Judit,Fábián Márk,Horváth Zoltán,Illyés Eszter,Markó Péter,Sipos Anna,Szántai-Kis Csaba,Szokol Bálint,Őrfi László

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference32 articles.

1. Cyclin-dependent kinases;Malumbres;Genom Biol,2014

2. Identification and cloning of a protein kinase-encoding mouse gene, Plk, related to the polo gene of Drosophila;Clay;PNAS,1993

3. The protein kinase complement of the human genome;Manning;Science,2002

4. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases;Brown;Nat Cell Biol,1999

5. Mammalian cyclin-dependent kinases;Malumbres;Trends Biochem Sci,2005

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of trilaciclib, a first-in-class cyclin-dependent kinase 4/6 inhibitor, for the management of metastatic small-cell lung cancer;Medicinal Chemistry Research;2024-07-26

2. Exploration of Potential Cyclin-dependent Kinases and their Inhibitors to Combat Abnormal Signalling and Cancer;Current Signal Transduction Therapy;2024-07

3. Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance;European Journal of Medicinal Chemistry;2024-05

4. Development and structure-activity relationship of tacrine derivatives as highly potent CDK2/9 inhibitors for the treatment of cancer;European Journal of Medicinal Chemistry;2022-11

5. CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells;Molecular Cancer;2022-04-22